Re: Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
Article Details
- CitationCopy to clipboard
Taneja SS
Re: Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
J Urol. 2012 Dec;188(6):2149.
- PubMed ID
- 23289116 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Nivolumab Programmed cell death protein 1 Protein Humans YesInhibitorAntibodyDetails